3D Global Biotech (ROCO:6808) COGS-to-Revenue : 0.80 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech COGS-to-Revenue?

3D Global Biotech's Cost of Goods Sold for the six months ended in Dec. 2023 was NT$9.14 Mil. Its Revenue for the six months ended in Dec. 2023 was NT$11.49 Mil.

3D Global Biotech's COGS to Revenue for the six months ended in Dec. 2023 was 0.80.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. 3D Global Biotech's Gross Margin % for the six months ended in Dec. 2023 was 20.46%.

3D Global Biotech COGS-to-Revenue Historical Data

The historical data trend for 3D Global Biotech's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech COGS-to-Revenue Chart

3D Global Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.56

0.63

0.84

0.80

0.74

3D Global Biotech Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial							1.33	0.75	0.84	0.68	0.80

3D Global Biotech COGS-to-Revenue Calculation

3D Global Biotech's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	15.359	/	20.633
	=	0.74

3D Global Biotech's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	9.135	/	11.485
	=	0.80

3D Global Biotech (ROCO:6808) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

3D Global Biotech's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	9.135 / 11.485
	=	20.46 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

3D Global Biotech COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Global Biotech (ROCO:6808) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Sec. 1, Xintai 5th Rd, 21st Floor -3, Xizhi District, New Taipei, TWN, 221

Website

http://www.3dglobalbiotech.com.tw

3D Global Biotech Inc is engaged in developing reconstruction of human tissues and organs and manufactures customized and personalized high-level medical devices.

3D Global Biotech (ROCO:6808) Headlines

No Headlines